
Faisal M. Zaman
Examiner (ID: 9195, Phone: (571)272-6495 , Office: P/2185 )
| Most Active Art Unit | 2111 |
| Art Unit(s) | 2186, 2112, 2185, 2111, 2175 |
| Total Applications | 1078 |
| Issued Applications | 682 |
| Pending Applications | 82 |
| Abandoned Applications | 333 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15898489
[patent_doc_number] => 20200148763
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-14
[patent_title] => Cellular Delivery of DNA Intercalating Agents
[patent_app_type] => utility
[patent_app_number] => 16/568702
[patent_app_country] => US
[patent_app_date] => 2019-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5768
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16568702
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/568702 | Cellular delivery of DNA intercalating agents | Sep 11, 2019 | Issued |
Array
(
[id] => 15678245
[patent_doc_number] => 20200093786
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-26
[patent_title] => SYNERGISTIC USE OF CANNABIS FOR TREATING MULTIPLE MYELOMA
[patent_app_type] => utility
[patent_app_number] => 16/559826
[patent_app_country] => US
[patent_app_date] => 2019-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15408
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16559826
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/559826 | SYNERGISTIC USE OF CANNABIS FOR TREATING MULTIPLE MYELOMA | Sep 3, 2019 | Abandoned |
Array
(
[id] => 16831053
[patent_doc_number] => 11007284
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-18
[patent_title] => Gas-encapsulated acoustically responsive stabilized microbubbles and methods for treating cardiovascular disease
[patent_app_type] => utility
[patent_app_number] => 16/558523
[patent_app_country] => US
[patent_app_date] => 2019-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7466
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16558523
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/558523 | Gas-encapsulated acoustically responsive stabilized microbubbles and methods for treating cardiovascular disease | Sep 2, 2019 | Issued |
Array
(
[id] => 15290427
[patent_doc_number] => 20190388349
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-26
[patent_title] => NON-TOXIC VEHICLE TO SOLUBILIZE, DELIVER, AND OBTAIN BIOLOGICAL ACTIVITY OF STEROID HORMONES AT CELL, TISSUE, AND ORGAN TARGETS, IN VITRO AND IN VIVO
[patent_app_type] => utility
[patent_app_number] => 16/557132
[patent_app_country] => US
[patent_app_date] => 2019-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4215
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16557132
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/557132 | NON-TOXIC VEHICLE TO SOLUBILIZE, DELIVER, AND OBTAIN BIOLOGICAL ACTIVITY OF STEROID HORMONES AT CELL, TISSUE, AND ORGAN TARGETS, IN VITRO AND IN VIVO | Aug 29, 2019 | Abandoned |
Array
(
[id] => 15586093
[patent_doc_number] => 20200069581
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-05
[patent_title] => CANNABINOID AND ANESTHETIC GUM AND LOZENGE COMPOSITIONS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 16/554930
[patent_app_country] => US
[patent_app_date] => 2019-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13633
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16554930
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/554930 | CANNABINOID AND ANESTHETIC GUM AND LOZENGE COMPOSITIONS AND METHODS | Aug 28, 2019 | Abandoned |
Array
(
[id] => 15586207
[patent_doc_number] => 20200069638
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-05
[patent_title] => CANNABINOID AND MENTHOL GUM AND LOZENGE COMPOSITIONS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 16/555022
[patent_app_country] => US
[patent_app_date] => 2019-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13567
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16555022
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/555022 | CANNABINOID AND MENTHOL GUM AND LOZENGE COMPOSITIONS AND METHODS | Aug 28, 2019 | Abandoned |
Array
(
[id] => 17154771
[patent_doc_number] => 20210315822
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => BIOMIMETIC REBUILDING OF MULTIFUNCTIONAL RED BLOOD CELLS
[patent_app_type] => utility
[patent_app_number] => 17/264452
[patent_app_country] => US
[patent_app_date] => 2019-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20394
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17264452
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/264452 | BIOMIMETIC REBUILDING OF MULTIFUNCTIONAL RED BLOOD CELLS | Jul 29, 2019 | Abandoned |
Array
(
[id] => 16923481
[patent_doc_number] => 11044931
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-29
[patent_title] => Low molecular weight modulators of the cold menthol receptor TRPM8 and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/524437
[patent_app_country] => US
[patent_app_date] => 2019-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42047
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 352
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16524437
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/524437 | Low molecular weight modulators of the cold menthol receptor TRPM8 and use thereof | Jul 28, 2019 | Issued |
Array
(
[id] => 17109556
[patent_doc_number] => 20210290153
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-23
[patent_title] => DRUG DELIVERY DEVICES HAVING ADSORBED MEDICATION ADHERENCE MARKERS THEREON, PACKAGING INCLUDING THE SAME AND METHODS OF FORMING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/261127
[patent_app_country] => US
[patent_app_date] => 2019-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2876
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17261127
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/261127 | DRUG DELIVERY DEVICES HAVING ADSORBED MEDICATION ADHERENCE MARKERS THEREON, PACKAGING INCLUDING THE SAME AND METHODS OF FORMING THE SAME | Jul 18, 2019 | Abandoned |
Array
(
[id] => 18186504
[patent_doc_number] => 11577063
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-14
[patent_title] => Soluble microneedle containing ingredient for controlling release of neurotransmitters
[patent_app_type] => utility
[patent_app_number] => 16/516867
[patent_app_country] => US
[patent_app_date] => 2019-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 4521
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16516867
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/516867 | Soluble microneedle containing ingredient for controlling release of neurotransmitters | Jul 18, 2019 | Issued |
Array
(
[id] => 17466666
[patent_doc_number] => 11273123
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-15
[patent_title] => Chewable pharmaceutical dosage forms
[patent_app_type] => utility
[patent_app_number] => 16/515982
[patent_app_country] => US
[patent_app_date] => 2019-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10398
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 188
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16515982
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/515982 | Chewable pharmaceutical dosage forms | Jul 17, 2019 | Issued |
Array
(
[id] => 15493295
[patent_doc_number] => 20200046836
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-13
[patent_title] => Terpene Carrier
[patent_app_type] => utility
[patent_app_number] => 16/506947
[patent_app_country] => US
[patent_app_date] => 2019-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9824
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16506947
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/506947 | Terpene Carrier | Jul 8, 2019 | Abandoned |
Array
(
[id] => 17161751
[patent_doc_number] => 11147834
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-19
[patent_title] => Composition for treatment or prevention of age-related macular degeneration comprising molecular hydrogen
[patent_app_type] => utility
[patent_app_number] => 16/428324
[patent_app_country] => US
[patent_app_date] => 2019-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5311
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16428324
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/428324 | Composition for treatment or prevention of age-related macular degeneration comprising molecular hydrogen | May 30, 2019 | Issued |
Array
(
[id] => 18259714
[patent_doc_number] => 11607398
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-03-21
[patent_title] => Chlorogenic acid composition and method of weight management
[patent_app_type] => utility
[patent_app_number] => 16/416709
[patent_app_country] => US
[patent_app_date] => 2019-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 16
[patent_no_of_words] => 9826
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16416709
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/416709 | Chlorogenic acid composition and method of weight management | May 19, 2019 | Issued |
Array
(
[id] => 16656001
[patent_doc_number] => 20210052637
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => MAGNETIC NANOPARTICLES FOR USE IN THE TREATMENT OF TUMORS
[patent_app_type] => utility
[patent_app_number] => 17/051329
[patent_app_country] => US
[patent_app_date] => 2019-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6891
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17051329
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/051329 | Magnetic nanoparticles for use in the treatment of tumors | May 2, 2019 | Issued |
Array
(
[id] => 17198729
[patent_doc_number] => 20210338823
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2021-11-04
[patent_title] => CERAMIDE-LIKE LIPID-BASED DELIVERY VEHICLES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/046753
[patent_app_country] => US
[patent_app_date] => 2019-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22993
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -101
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17046753
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/046753 | Ceramide-like lipid-based delivery vehicles and uses thereof | Apr 11, 2019 | Issued |
Array
(
[id] => 17198729
[patent_doc_number] => 20210338823
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2021-11-04
[patent_title] => CERAMIDE-LIKE LIPID-BASED DELIVERY VEHICLES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/046753
[patent_app_country] => US
[patent_app_date] => 2019-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22993
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -101
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17046753
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/046753 | Ceramide-like lipid-based delivery vehicles and uses thereof | Apr 11, 2019 | Issued |
Array
(
[id] => 14963057
[patent_doc_number] => 20190309006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-10
[patent_title] => HIGH-PURITY STEVIOL GLYCOSIDES
[patent_app_type] => utility
[patent_app_number] => 16/382047
[patent_app_country] => US
[patent_app_date] => 2019-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29820
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16382047
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/382047 | HIGH-PURITY STEVIOL GLYCOSIDES | Apr 10, 2019 | Abandoned |
Array
(
[id] => 16686902
[patent_doc_number] => 20210069377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => TISSUE SCAFFOLD
[patent_app_type] => utility
[patent_app_number] => 17/046187
[patent_app_country] => US
[patent_app_date] => 2019-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16696
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -39
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17046187
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/046187 | TISSUE SCAFFOLD | Apr 10, 2019 | Abandoned |
Array
(
[id] => 19121149
[patent_doc_number] => 11965120
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-23
[patent_title] => Gel adhesive comprising crosslinked blend of polydiorganosiloxane and acrylic polymer
[patent_app_type] => utility
[patent_app_number] => 16/968956
[patent_app_country] => US
[patent_app_date] => 2019-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10968
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16968956
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/968956 | Gel adhesive comprising crosslinked blend of polydiorganosiloxane and acrylic polymer | Apr 2, 2019 | Issued |